Department of Biomedicine, Neuroscience and Advanced Diagnostics (Bi.N.D.), University of Palermo, Palermo, Italy.
Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome, Italy.
Mol Biol Rep. 2020 Apr;47(4):3117-3131. doi: 10.1007/s11033-020-05353-2. Epub 2020 Mar 3.
Stem cell therapy (SCT), born as therapeutic revolution to replace pharmacological treatments, remains a hope and not yet an effective solution. Accordingly, stem cells cannot be conceivable as a "canonical" drug, because of their unique biological properties. A new reorientation in this field is emerging, based on a better understanding of stem cell biology and use of cutting-edge technologies and innovative disciplines. This will permit to solve the gaps, failures, and long-term needs, such as the retention, survival and integration of stem cells, by employing pharmacology, genetic manipulation, biological or material incorporation. Consequently, the clinical applicability of SCT for chronic human diseases will be extended, as well as its effectiveness and success, leading to long-awaited medical revolution. Here, some of these aspects are summarized, reviewing and discussing recent advances in this rapidly developing research field.
干细胞治疗(SCT)作为替代药物治疗的治疗革命,仍然是一种希望而非有效的解决方案。因此,由于其独特的生物学特性,干细胞不能被想象为一种“规范”药物。基于对干细胞生物学的更好理解以及对先进技术和创新学科的利用,该领域正在出现新的重新定位。这将通过药理学、遗传操作、生物或材料结合来解决保留、存活和整合干细胞等差距、失败和长期需求。因此,SCT 治疗慢性人类疾病的临床适用性将得到扩展,其有效性和成功率也将提高,从而带来期待已久的医学革命。在这里,总结了其中的一些方面,回顾和讨论了这个快速发展的研究领域的最新进展。